Bilcare improved its product range to offer high margin products and solutions for innovative packaging. While it is still ‘work in progress’ to derive the full benefits from the acquisition, the businesses have advanced against the initial goals and the progress already achieved will underpin earnings growth for the next two years. Through this acquisition, the company now enjoys a strong base of over 2,000 customers spread across the globe.
It is their aim to innovate and develop pioneering packaging solutions to meet the complex needs of the pharmaceutical industry. With their integrated services, we enable clients to focus on their core business, i.e.
development of new drug molecules, formulation development, manufacturing and
marketing while we partner with them in the area of drug stabilization and
protection. They help customers capitalize on upcoming trends, through products
that maximize the commercial potential and efficacy of drugs.
Bilcare is at the forefront of delivering sustainable, affordable
and innovative packaging solutions to customers globally. As a research driven organization
with single source capabilities, we follow a customer centric approach to
fulfill packaging needs in the areas of pharmaceutical packaging, card solutions
and specialty films. We have supplemented our research and development
capabilities with broad production and application knowledge as a single source
packaging solutions provider. We leverage the powerful synergy of our research
capabilities in India, Singapore and Germany; State-of-the-art design and
manufacturing facilities in US, Germany, Italy, Singapore & India and above
all, our commitment to create sustainable competitive advantages for our
customers.
No comments:
Post a Comment